-
1
-
-
0035424063
-
Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate
-
Pilepich M.V., Winter K., John M.J., et al. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001, 50(5):1243-1252.
-
(2001)
Int J Radiat Oncol Biol Phys
, vol.50
, Issue.5
, pp. 1243-1252
-
-
Pilepich, M.V.1
Winter, K.2
John, M.J.3
-
2
-
-
0030933348
-
Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer
-
Laverdiere J., Gomez J.L., Cusan L., et al. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer. Int J Radiat Oncol Biol Phys 1997, 37(2):247-252.
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.37
, Issue.2
, pp. 247-252
-
-
Laverdiere, J.1
Gomez, J.L.2
Cusan, L.3
-
3
-
-
1542267900
-
The efficacy and sequencing of a short course of androgen suppression on freedom from biochemical failure when administered with radiation therapy for T2-T3 prostate cancer
-
Laverdiere J., Nabid A., de Bedoya L.D., et al. The efficacy and sequencing of a short course of androgen suppression on freedom from biochemical failure when administered with radiation therapy for T2-T3 prostate cancer. J Urol 2004, 171:1137-1140.
-
(2004)
J Urol
, vol.171
, pp. 1137-1140
-
-
Laverdiere, J.1
Nabid, A.2
de Bedoya, L.D.3
-
4
-
-
79955470908
-
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10 year data from the TROG 96.01 randomised trial
-
Denham J.W., Steigler A., Lamb D.S., et al. Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10 year data from the TROG 96.01 randomised trial. Lancet Oncol 2011, 12:451-459.
-
(2011)
Lancet Oncol
, vol.12
, pp. 451-459
-
-
Denham, J.W.1
Steigler, A.2
Lamb, D.S.3
-
5
-
-
0035869725
-
Updated results of the phase III radiation therapy oncology group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate
-
Lawton C.A., Winter K., Murray K., et al. Updated results of the phase III radiation therapy oncology group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001, 49(4):937-946.
-
(2001)
Int J Radiat Oncol Biol Phys
, vol.49
, Issue.4
, pp. 937-946
-
-
Lawton, C.A.1
Winter, K.2
Murray, K.3
-
6
-
-
0037072063
-
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
-
Bolla M., Collette L., Blank L., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002, 360:103-108.
-
(2002)
Lancet
, vol.360
, pp. 103-108
-
-
Bolla, M.1
Collette, L.2
Blank, L.3
-
7
-
-
78049527402
-
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
-
Bolla M., van Tienhoven G., Warde P., et al. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. Lancet Oncol 2010, 11:1066-1073.
-
(2010)
Lancet Oncol
, vol.11
, pp. 1066-1073
-
-
Bolla, M.1
van Tienhoven, G.2
Warde, P.3
-
8
-
-
58649103315
-
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
-
Widmark A., Klepp O., Solberg A., et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009, 373:301-308.
-
(2009)
Lancet
, vol.373
, pp. 301-308
-
-
Widmark, A.1
Klepp, O.2
Solberg, A.3
-
9
-
-
83955165856
-
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
-
Warde P., Mason M., Ding K., et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011, 378:2104-2111.
-
(2011)
Lancet
, vol.378
, pp. 2104-2111
-
-
Warde, P.1
Mason, M.2
Ding, K.3
-
10
-
-
0037674063
-
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: radiation therapy oncology group 9413
-
Roach M., DeSilvio M., Lawton C., et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: radiation therapy oncology group 9413. J Clin Oncol 2003, 21(10):1904-1911.
-
(2003)
J Clin Oncol
, vol.21
, Issue.10
, pp. 1904-1911
-
-
Roach, M.1
DeSilvio, M.2
Lawton, C.3
-
11
-
-
34548682063
-
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions
-
Lawton C.A., DeSilvio M., Roach M., et al. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat Oncol Biol Phys 2007, 69(3):646-655.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.69
, Issue.3
, pp. 646-655
-
-
Lawton, C.A.1
DeSilvio, M.2
Roach, M.3
-
12
-
-
10644259702
-
The effectiveness of combining hormone therapy and radiotherapy in the treatment of prostate cancer
-
Jani A.B. The effectiveness of combining hormone therapy and radiotherapy in the treatment of prostate cancer. Expert Opin Pharmacother 2004, 5(12):2469-2477.
-
(2004)
Expert Opin Pharmacother
, vol.5
, Issue.12
, pp. 2469-2477
-
-
Jani, A.B.1
-
13
-
-
0344844488
-
Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma: a complication-adjusted number needed-to-treat analysis
-
Jani A.B., Kao J., Hellman S. Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma: a complication-adjusted number needed-to-treat analysis. Cancer 2003, 98(11):2351-2361.
-
(2003)
Cancer
, vol.98
, Issue.11
, pp. 2351-2361
-
-
Jani, A.B.1
Kao, J.2
Hellman, S.3
-
14
-
-
31044434562
-
Impact of hormone therapy on acute radiotherapy toxicity in the treatment of prostate cancer
-
Jani A.B., Gratzle J., Myers M. Impact of hormone therapy on acute radiotherapy toxicity in the treatment of prostate cancer. Prostate Cancer Prostatic Dis 2005, 8(3):224-228.
-
(2005)
Prostate Cancer Prostatic Dis
, vol.8
, Issue.3
, pp. 224-228
-
-
Jani, A.B.1
Gratzle, J.2
Myers, M.3
-
15
-
-
0642311912
-
Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the radiation therapy oncology group protocol 92-02
-
Hanks G.E., Pajak T.E., Porter A., et al. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the radiation therapy oncology group protocol 92-02. J Clin Oncol 2003, 21(21):3872-3978.
-
(2003)
J Clin Oncol
, vol.21
, Issue.21
, pp. 3872-3978
-
-
Hanks, G.E.1
Pajak, T.E.2
Porter, A.3
-
16
-
-
67149125847
-
Duration of androgen suppression in the treatment of prostate cancer
-
Bolla M., de Reijke T.M., van Tienhoven G., et al. Duration of androgen suppression in the treatment of prostate cancer. N Engl J Med 2009, 360:2516-2527.
-
(2009)
N Engl J Med
, vol.360
, pp. 2516-2527
-
-
Bolla, M.1
de Reijke, T.M.2
van Tienhoven, G.3
-
17
-
-
84921803278
-
High-risk prostate cancer treated with pelvic radiotherapy and 36 versus 18 months of androgen blockade: results of a phase III randomized study
-
abstract #3
-
Nabid A, et al. High-risk prostate cancer treated with pelvic radiotherapy and 36 versus 18 months of androgen blockade: results of a phase III randomized study. Proceedings of the ASCO/ASTRO/SUO Genitourinary Cancers Symposium; 2013 abstract #3: p91.
-
(2013)
Proceedings of the ASCO/ASTRO/SUO Genitourinary Cancers Symposium
, pp. 91
-
-
Nabid, A.1
-
18
-
-
84888337623
-
Sequencing of agents for castration-resistant prostate cancer
-
Hurwitz M., Petrylak D.P. Sequencing of agents for castration-resistant prostate cancer. Oncology 2013, 27(11):1144-1158.
-
(2013)
Oncology
, vol.27
, Issue.11
, pp. 1144-1158
-
-
Hurwitz, M.1
Petrylak, D.P.2
-
19
-
-
84921825921
-
Phase III trial of dose escalated radiation therapy and standard androgen deprivation therapy (ADT) with a GnRH agonist vs. dose escalated radiation therapy and enhanced ADT with a GnRH agonist and TAK-700 for men with high risk prostate cancer
-
Accessed 21.07.14.
-
Radiation Therapy Oncology Group trial 1115. Phase III trial of dose escalated radiation therapy and standard androgen deprivation therapy (ADT) with a GnRH agonist vs. dose escalated radiation therapy and enhanced ADT with a GnRH agonist and TAK-700 for men with high risk prostate cancer. ; Accessed 21.07.14. http://www.rtog.org.
-
-
-
-
20
-
-
84921794605
-
Androgen deprivation therapy and high dose radiotherapy with or without whole-pelvic radiotherapy in unfavorable intermediate or favorable high-risk prostate cancer: a phase III randomized trial.
-
Accessed 21.07.14.
-
Radiation Therapy Oncology Group trial 0924. Androgen deprivation therapy and high dose radiotherapy with or without whole-pelvic radiotherapy in unfavorable intermediate or favorable high-risk prostate cancer: a phase III randomized trial. ; Accessed 21.07.14. http://www.rtog.org.
-
-
-
-
21
-
-
79960227242
-
Radiotherapy and short-term androgen deprivation for localized prostate cancer
-
Jones C.U., Hunt D., McGowan D.G., et al. Radiotherapy and short-term androgen deprivation for localized prostate cancer. N Engl J Med 2011, 365:107-118.
-
(2011)
N Engl J Med
, vol.365
, pp. 107-118
-
-
Jones, C.U.1
Hunt, D.2
McGowan, D.G.3
-
22
-
-
13844253671
-
Hormone therapy adjuvant to external beam radiotherapy for early prostate cancer: a complication-adjusted number-needed to treat (NNT) analysis
-
Jani A.B., Kao J., Heimann R., Hellman S. Hormone therapy adjuvant to external beam radiotherapy for early prostate cancer: a complication-adjusted number-needed to treat (NNT) analysis. Int J Radiat Oncol Biol Phys 2005, 61(3):687-694.
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.61
, Issue.3
, pp. 687-694
-
-
Jani, A.B.1
Kao, J.2
Heimann, R.3
Hellman, S.4
-
23
-
-
84863629926
-
High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: cancer control and toxicity outcomes
-
Edelman S., Liauw S.L., Rossi P.J., Cooper S., Jani A.B. High-dose radiotherapy with or without androgen deprivation therapy for intermediate-risk prostate cancer: cancer control and toxicity outcomes. Int J Radiat Oncol Biol Phys 2012, 83(5):1473-1479.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.83
, Issue.5
, pp. 1473-1479
-
-
Edelman, S.1
Liauw, S.L.2
Rossi, P.J.3
Cooper, S.4
Jani, A.B.5
-
24
-
-
84921767469
-
A phase III prospective randomized trial of dose-escalated radiotherapy with or without short-term androgen-deprivation therapy for patients with intermediate-risk prostate cancer.
-
Accessed 21.07.14.
-
Radiation Therapy Oncology Group trial 0815. A phase III prospective randomized trial of dose-escalated radiotherapy with or without short-term androgen-deprivation therapy for patients with intermediate-risk prostate cancer. ; Accessed 21.07.14. http://www.rtog.org.
-
-
-
-
25
-
-
0034644401
-
Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer
-
D'Amico A.V., Schultz D., Loffredo M., et al. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. J Am Med Assoc 2000, 284:1280-1283.
-
(2000)
J Am Med Assoc
, vol.284
, pp. 1280-1283
-
-
D'Amico, A.V.1
Schultz, D.2
Loffredo, M.3
|